Stock BGBIO BERGENBIO ASA
Add to a list
To use this feature you must be a member
Log inSign up

Consensus BerGenBio ASA

Equities

BGBIO

NO0010650013

Market Closed - Oslo Bors
Other stock markets
 10:45:00 2024-05-03 EDT 		5-day change 1st Jan Change
0.1424 NOK -1.66% Intraday chart for BerGenBio ASA -5.32% -48.78%
03-20 Bergenbio Announces Initiation of Phase 2A in First Line Non-Small Lung Cancer Patients with A STK11 Mutation CI
02-14 BerGenBio ASA Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Evolution of the average Target Price on BerGenBio ASA

Price target over the last 5 years

History of analyst recommendation changes

7a4f7dd23d095.rP9zXWPqb7x5vAWXJhyP_gqhkjqBh2CyGbkEU9LydLQ.xpsdOQSJIY8J9FT2FFe-mEDg1XHxywX7YfVcJIixLvzuxxoHANIo2xHMTA~5ad85259150bb4383f94226f64a9578b

Analyst Recommendations on BerGenBio ASA

BerGenBio Reports 43% Response Rate With Bemcentinib Monotherapy in AXL Positive R/R AML/MDS Patients at ASH CI
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
2
Last Close Price
0.1424 NOK
Average target price
0.7667 NOK
Spread / Average Target
+438.39%
High Price Target
2 NOK
Spread / Highest target
+1,304.49%
Low Price Target
0.05 NOK
Spread / Lowest Target
-64.89%

Consensus detail

Consensus revision (last 18 months)

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. BGBIO Stock
  4. Consensus BerGenBio ASA